Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
- Conditions
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 269
- Registration Number
- NCT05846230
- Locations
- 🇺🇸
Newport Native MD, Inc, Newport Beach, California, United States
🇺🇸University of California Davis, Sacramento, California, United States
🇺🇸Malcom Randall VA Medical Center, Gainesville, Florida, United States
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 27
- Registration Number
- NCT05839600
- Locations
- 🇺🇸
NEXT Oncology-San Antonio-65273, San Antonio, Texas, United States
🇺🇸Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
A Study in Healthy Men to Test How BI 1291583 is Processed in the Body
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 8
- Registration Number
- NCT05833035
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1810631 in the Blood
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT05833139
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
- Conditions
- Interventions
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 200
- Registration Number
- NCT05819398
- Locations
- 🇦🇺
Holdsworth House Medical Practice, Sydney, New South Wales, Australia
🇺🇸Palmetto Clinical Trial Services, Greenville, South Carolina, United States
🇦🇷Hospital Italiano de Buenos Aires, Caba, Argentina
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
- Conditions
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 312
- Registration Number
- NCT05819385
Dose Reduction and Discontinuation With Anti-Fibrotic Medications
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 2778
- Registration Number
- NCT05779007
- Locations
- 🇺🇸
Boehringer Ingelheim, Ridgefield, Connecticut, United States
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
- Conditions
- Interventions
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 88
- Registration Number
- NCT05751226
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT05741385
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT05741372
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany